Growth Metrics

Evolent Health (EVH) Change in Accured Expenses (2016 - 2026)

Evolent Health has reported Change in Accured Expenses over the past 11 years, most recently at $7.4 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 118.24% year-over-year to $7.4 million; the TTM value through Dec 2025 reached $3.0 million, up 113.04%, while the annual FY2025 figure was $3.0 million, 113.04% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $7.4 million at Evolent Health, up from $1.5 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $26.8 million in Q2 2024 and troughed at -$40.3 million in Q4 2024.
  • A 5-year average of -$1.1 million and a median of $2.6 million in 2021 define the central range for Change in Accured Expenses.
  • Biggest five-year swings in Change in Accured Expenses: plummeted 1330.38% in 2021 and later skyrocketed 606.76% in 2023.
  • Year by year, Change in Accured Expenses stood at $17.4 million in 2021, then tumbled by 105.09% to -$888000.0 in 2022, then plummeted by 337.39% to -$3.9 million in 2023, then crashed by 938.18% to -$40.3 million in 2024, then soared by 118.24% to $7.4 million in 2025.
  • Business Quant data shows Change in Accured Expenses for EVH at $7.4 million in Q4 2025, $1.5 million in Q3 2025, and $13.0 million in Q2 2025.